Assignment 3: Polypharmacy definitions
Purpose The purpose of student discussions is to provide the opportunity for a deeper understanding of polypharmacy Activity Learning Outcomes Through this discussion, the student will demonstrate the ability to:
Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1)
Assignment help – Discuss polypharmacy risk factors (WO1.5) (CO1)
Explain the actions steps for polypharmacy prevention (WO1.5) (CO1, 7)
Provide an example of how your clinical preceptors have addressed polypharmacy.
Please READ the RUBRIC. The paper must be in accordance with my instructor requests in the rubric.
Through this discussion, the student will demonstrate the ability to:
1. Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1)
2. Assignment help – Discuss polypharmacy risk factors (WO1.5) (CO1)
3. Explain thee actions steps for polypharmacy prevention (WO1.5) (CO1, 7)
Total Points Possible:
50 points
Requirements:
Your initial discussion post should include the following:
1. Identify and discuss 2-3 definitions of polypharmacy (there are multiple definitions). Your textbook (Kennedy-Malone, L., Plank, L. M., & Duffy, E. G. (2019). Advanced practice nursing in the care of older adults (2nd ed.). Philadelphia: F.A. Davis Company) can count as 1 reference. You must also include an additional reference from an evidence-based practice journal article or national guideline (within last 5 years). Find and talk about two or three definitions of polypharmacy (there are multiple definitions). Your book (Kennedy-Malone, L., Plank, L. M., and Duffy, E. G.) tells you about this (2019). Care for older people by nurses with more experience (2nd ed.). This is one reference. You must also include a second reference from a journal article or national guideline that is based on evidence-based practice (within last 5 years).
2. Identify three risk factors that can lead to polypharmacy. Explain the rationale for why each listed item is a risk factor. Risk factors are different than adverse drug reactions. ADRs can be a result of polypharmacy, and is important, but ADRs are not a risk factor.
3. Explore three action steps that a provider can take to prevent polypharmacy.
4. Provide an example of how your clinical preceptors have addressed polypharmacy.
